Abstract

In a previous study we have shown that public buses in Oporto, the second largest city in Portugal, were highly contaminated with MRSA. Here we describe the results of a similar study performed in another urban area of Portugal–Lisbon, the capital. Between May 2011 and May 2012, hand touched surfaces of 199 public buses in Lisbon were screened for MRSA contamination. Subsequently, the hands of 575 passengers who frequently use these bus lines were also screened. All hand carriers of MRSA were further screened for nasal carriage. The isolates were characterized by PFGE, staphylococcal cassette chromosome (SCC) mec typing, spa typing, MLST and were tested for the presence of mecA, Panton-Valentine leukocidin and arginine catabolic mobile element genes. MRSA contamination was shown in 72 buses (36.2%). The majority of the isolates belonged to three major clones: Clone A was identified as EMRSA-15 defined by pattern PFGE A, spa types t2357/t747/t025/t379/t910, ST22, and SCCmec IVh (n = 21; 29%). Clone B was the New York/Japan clone characterized by PFGE B-t002/t10682-ST5-II (n = 15; 21%). Clone C included isolates with characteristics of the international community-acquired USA300 or related clones, PFGE C-t008-ST8-IVa/IVc/IVg/IVnt/VI (n = 19; 26%). The first two clones are currently the two major lineages circulating in Portuguese hospitals. The hands of 15 individuals were contaminated with MRSA belonging to the nosocomial clones A or B. Eleven of these individuals were not nasal carriers of MRSA and all but one had travelled by public transportation, namely by bus, prior to sampling. In conclusion, public buses in two major cities in Portugal are often contaminated with MRSA representing clones dominant in hospitals in the particular geographic area. MRSA contamination of public transport and the transfer of the bacteria to the hands of passengers may represent a route through which hospital-acquired MRSA clones may spread to the community.

Highlights

  • Methicillin-resistant Staphylococcus aureus (MRSA) is a major healthcare associated (HA-MRSA) human pathogen responsible for mild to severe life threatening infections worldwide [1,2]

  • A major concern for public health emerged with the blurring of the molecular and epidemic boundaries between HA- and CAMRSA: CA-MRSA strains originally confined to the community are increasingly causing healthcare-acquired infections as indicated by the rise in the proportion of USA300 isolates causing invasive infections in United States hospitals [6,7]

  • A few highly disseminated clones are currently responsible for HA-MRSA infections in the country, namely EMRSA-15 (ST22IV) – which has been endemic in Portuguese hospitals since 2001 and the New York/Japan clone (ST5-II), which is currently the second most prevalent lineage [8,9,10,11]

Read more

Summary

Introduction

Methicillin-resistant Staphylococcus aureus (MRSA) is a major healthcare associated (HA-MRSA) human pathogen responsible for mild to severe life threatening infections worldwide [1,2]. A major concern for public health emerged with the blurring of the molecular and epidemic boundaries between HA- and CAMRSA: CA-MRSA strains originally confined to the community are increasingly causing healthcare-acquired infections as indicated by the rise in the proportion of USA300 isolates causing invasive infections in United States hospitals [6,7]. A few highly disseminated clones are currently responsible for HA-MRSA infections in the country, namely EMRSA-15 (ST22IV) – which has been endemic in Portuguese hospitals since 2001 and the New York/Japan clone (ST5-II), which is currently the second most prevalent lineage [8,9,10,11]. CA-MRSA clonal lineages, as the European clone (ST80-IVc) or the USA300 clone (ST8-IVa) producing PVL, were sporadically reported in Portugal only in cases where the existence of hospital risk factors could not be eliminated [12,15,16]

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call